Developing human laboratory models of smoking lapse behavior for medication screening

Area of Science:

• Behavioral Science
• Pharmacology
• Addiction Medicine

Background:

• Human laboratory models are vital for evaluating smoking cessation medications.
• Existing models do not adequately capture smoking lapse behavior, a key predictor of relapse.
• Smoking lapse is a critical target for developing effective medications.

Purpose of the Study:

• To outline a three-stage process for developing a human laboratory model of smoking lapse behavior.
• To create a paradigm for medication screening focused on smoking abstinence.
• To model the critical features of lapse behavior: resistance to the first cigarette and subsequent smoking.

Main Methods:

• Exposing participants to smoking relapse precipitants (nicotine deprivation, alcohol, stress).
• Assessing participants' ability to resist smoking a preferred brand cigarette.
• Modeling subsequent tobacco self-administration following a lapse.

Main Results:

• The developed model effectively simulates key aspects of smoking lapse behavior.
• The model allows for mechanistic evaluation of medication effects on smoking behavior.
• Validation of the model for medication screening is ongoing.

Conclusions:

• A novel human laboratory model for smoking lapse has been developed.
• This model facilitates efficient and cost-effective screening of smoking cessation medications.
• The model supports translational research in nicotine dependence treatment.